Retatrutide 30 mg
Retatrutide is an investigational triple receptor agonist associated with GIP, GLP-1, and glucagon receptor research. It is studied in laboratory and investigational research settings involving metabolic signaling, endocrine pathways, and receptor activity models.
No dosing, administration, or human-use guidance is provided. Submissions are reviewed for qualified research use.
Product Overview
Retatrutide is an investigational triple receptor agonist associated with GIP, GLP-1, and glucagon receptor research. It is studied in laboratory and investigational research settings involving metabolic signaling, endocrine pathways, and receptor activity models.
Package Information
- Product
- Retatrutide 30 mg
- Form
- Lyophilized Powder
- Purity
- ≥ 98%
- Storage
- Store at 2–8°C
- Category
- Research Peptide
- Price
- $180.00
Compound Facts
- Compound type
- Investigational research peptide
- Primary pathway
- GIP, GLP-1, and glucagon receptors
- Research category
- Metabolic and endocrine research
- Form
- Lyophilized
- Research status
- Investigational
- Intended use
- Laboratory research only
- Human or veterinary use
- Not permitted
Research Information
Neutral, research-context information on the pathways and laboratory work involving this compound. None of the content below describes human use, dosing, or medical application.
- Investigational compound studied across GIP, GLP-1, and glucagon receptor pathways.
- Used in laboratory models exploring multi-receptor metabolic signaling.
- Researched for ligand-bias and comparative agonist studies.
- Not an approved consumer product. Research use only.
Investigated for activity across three distinct receptor families - GIP, GLP-1, and glucagon - in receptor-pharmacology and cell-based signaling assays.
Used in models researching hepatic glucose output, energy expenditure signaling, and incretin pathway crosstalk in a laboratory setting.
Frequently included in side-by-side research with semaglutide and tirzepatide to characterize receptor selectivity and signaling profiles.
Retatrutide is investigational. It is described on this site only as a research compound; there is no approved consumer product form.
Product Overview
Retatrutide 30 mg is supplied by Blue Peak Health as a lyophilized investigational research peptide for triple-receptor pharmacology and metabolic signaling research. It is described on this site strictly as a research compound — there is no approved consumer product form. Every shipment is documented and batch-tracked for use in qualified laboratory workflows.
Research Applications
Investigated for activity across GIP, GLP-1, and glucagon receptor families in cell-based signaling assays.
Studied in models of hepatic glucose output, energy expenditure signaling, and incretin pathway crosstalk.
Used alongside semaglutide and tirzepatide reference peptides to characterize receptor selectivity and ligand bias.
Compound Information
Retatrutide is an investigational triple agonist peptide associated with GIP, GLP-1, and glucagon receptor research. It is supplied lyophilized for reconstitution in qualified laboratory environments and is positioned solely as a research material.
Further pathway context is available on our research facts page.
Storage & Handling
- Store in a controlled laboratory environment per accepted protocols for the compound class.
- Protect from direct light, heat, and ambient moisture during storage and handling.
- Reseal containers immediately after sampling to preserve batch integrity.
- Handle only in qualified research environments using appropriate PPE.
- Follow institutional chemical hygiene and biosafety guidelines at all times.
- Not intended for injection, ingestion, topical use, or use in humans or animals.
Quality Standards
- Purity target of 98% or higher across reference batches.
- Unique batch identifier supplied with every shipment for full traceability.
- Certificate of Analysis available on request for qualified researchers.
- Characterized with standard analytical methods appropriate to the compound class.
- Labeled and supplied strictly as a research material — never as a medicine, supplement, food, or cosmetic.
Full quality standards apply to every batch.
Frequently Asked Questions
Is this material intended for human or veterinary use?+
No. All Blue Peak Health materials are supplied strictly for laboratory research use only and are not intended for human or veterinary consumption, administration, or application of any kind.
Is documentation available for each batch?+
Yes. Each shipment carries a unique batch identifier, and a Certificate of Analysis can be requested by qualified researchers to support analytical and laboratory workflows.
Who is permitted to purchase research materials?+
Only qualified researchers, laboratories, and institutions purchasing for lawful in-vitro research and analytical work. Submissions are reviewed before fulfilment.
Are dosing or administration instructions provided?+
No. Blue Peak Health does not provide dosing, administration, injection, ingestion, or human-use instructions of any kind. Materials are supplied for the bench only.
More questions answered in our full FAQ.
Research Disclaimer
Retatrutide is investigational and is not sold as a drug, medicine, supplement, or consumer product.
For research use only. Not for human or veterinary consumption. Not a drug, food, dietary supplement, or cosmetic. Not intended to diagnose, treat, cure, or prevent any disease.
Inquire about Retatrutide 30 mg
Submit a research inquiry to request details, certificate of analysis, and availability. Reviewed for qualified researchers and laboratories only.